Drug treatments

I’ve been a myeloma patient for 25 years and am probably the longestsurviving patient in the world. I’m on weekly chemotherapy — Bortezomib and dexamethasone. That Daratumumab is not yet available here (NZ Herald, November 21) is of no importance to patients in the early stages of treatment. The reason is straightforward — there are a good half dozen effective drugs and drug combinations available to patients before they might have to move on to Daratumumab. The chances are very high that the subject of your article, Nichola Oakenfull, will die with myeloma rather than of myeloma.

David Nicholson